A mysterious killer travels the world

Public health experts have warned for decades that overuse of antibiotics reduces the effectiveness of drugs that cure bacterial infections. At least 2,000,000 Americans each year contract antibiotic-resistant infections.

Notably, the gluttonous overuse of antimicrobials to fight against bacteria and fungi in hospitals, clinics and farms is counterproductive and produces superbugs or "nightmare bacteria", particularly deadly for people to systems. Compromised immune and autoimmune diseases that use steroids to suppress the body's defenses. .

The Federal Centers for Disease Control and Prevention (CDC) recently called an "urgent threat" a fungus called Candida auris or C. auris. This Nightmare bacteria is a brutal killer that spreads quickly and thoroughly.

The CDC says that antibiotic resistance is "one of the biggest public health problems of our time."

According to the World Health Organization: "The world faces an apocalypse with antibiotics."

According to the British medical official, antimicrobial resistance: "May mean the end of modern medicine", while routine surgeries turn into medical emergencies.

In short, new antibiotic resistance mechanisms are emerging and spreading rapidly around the world. Informed sources fear that society in general is heading for a "post-antibiotic era," in which common infections and minor injuries can kill again (Source: WHO Fact Sheet). on antibiotic resistance, Nov. 2017).

According to a recent British government study, without new drugs and without limiting the unnecessary use of antimicrobial drugs, infections followed by subsequent deaths are likely to overshadow cancer deaths in the decades to come. The fact is that nearly half of the patients contracted by C. auris die within 90 days. (Source: Pew Campaign on Human Health and Industrial Agriculture)

Nowadays, the dangers of "nightmare bacteria" are becoming uncontrollable. The final concern is that C. auris will begin to spread to healthier populations, even though healthy people are not normally at risk. In just five years, C.auris has emerged as one of the most intractable health threats in the world. Resistant to drugs, stubborn and almost impossible to exterminate, he travels the world in search of innocent victims, most of the time killing in hospitals.

C.auris has already established a beachhead in Venezuela, Spain, the United Kingdom, India, Pakistan, South Africa, New York, New Jersey and Illinois. Nobody knows where else it can be cloaking.

A British hospital has aerosolized hydrogen peroxide in a room infected with C.auris for a week in the solid state. Subsequently, only one organism developed in a Petri dish in the room. It was C. auris. The hospital serves wealthy patients from Europe and the Middle East and has not publicly announced the outbreak.

An epidemic of C. auris in a Spanish hospital caused the death of 41% of infected patients. The hospital has not publicly announced the outbreak.

In the United States, the Brooklyn Branch of Mount Sinai Hospital had a case of C. auris with an elderly man hospitalized for abdominal surgery.

According to a New York Times article of April 7, 2019: Deadly germs, lost cures: a mysterious infection infecting the entire world in a secret climate: "The man from Mount Sinai died after 90 days in the morning. hospital, but C. Auris does not have it. Tests showed that the room was ubiquitous in the room, so invasive that the hospital needed special cleaning equipment and had to tear off some of the floor and floor tiles to eliminate it. C. auris is so persistent, in part, because it is impervious to antifungal medications, making it another example of one of the world's most intractable health threats: the recrudescence of resistant. "

Indeed, the public visibility of Mount Sinai is an exception, as hospitals and government agencies keep the location of C.auris. Public transparency is avoided. Hospitals and local governments are reluctant to divulge outbreaks because of fears over reputational reputation and the spread of rumors. Even the Center for Disease Control is not allowed, under a pact with states, to publicly announce outbreaks.

Epidemics of antibiotic-resistant infections have multiple causes. With respect to any of them, the use of antifungals on crops to prevent rot in turn contributes to the contamination of people with drug resistant fungi. In addition, it is well known that antibiotics are widely used (in fact, they are used too much by country) to prevent livestock diseases.

"In fact, researchers estimate that up to 70% of all antibiotics sold in the United States are administered to healthy food animals to artificially accelerate growth and offset the effects of unhealthy farm conditions. . This systematic use of antibiotics in animals represents a serious and growing threat to human health as it creates new strains of antibiotic-resistant bacteria. (Source: How are antibiotics used on farms contributing to the spread of resistant bacteria?) Scientific American magazine

In addition, and of serious deliberate interest, Denmark bears witness to what is happening by limiting the non-therapeutic use of antibiotics in cattle, broilers and pigs. Following the restrictions imposed by Denmark, the use of antibiotics for pigs decreased by 50% between 1992 and 2008. Results: (1) pig production increased by almost 50% and (2) antibiotic resistance in the man has decreased.

In contrast, in the United States, up to 70% of antibiotics are administered to farm animals that are not sick.

An urgent problem is that no new class of antibiotics has been invented for decades. In fact, all the antibiotics on the market in the last 30 years are variants of the existing drugs discovered in 1984, which means that they are only compounds of follow-up, without any innovative mechanism of action, which does not means no major breakthrough.

In a problematic way, only a few large pharmaceutical companies are involved in antibiotic research and development because the cost of drug development is high and profit margins are slim. In this regard, according to the Center for Research and Policy on Infectious Diseases: the pipeline of antibiotics is about to collapse and the country must act now to preserve the necessary infrastructure for the research and development in antibiotics.

The Pew Charitable Trust / Antibiotic Resistance Project is trying to mobilize the public in favor of the Law on the Preservation of Antibiotics for Medical Treatment (PAMTA, HR 1587 / S. 619), which removes the use of seven classes of drugs. Antibiotics of vital importance to human health, unless the animals are sick or that the pharmaceutical companies prove that their use does not harm human health.

Other advocacy groups include the American Medical Association, the American Academy of Pediatricians, the American Society of Infectious Diseases and the World Health Organization.

In a letter to congressional leaders on February 5, 2019, the Pew Charitable Trusts, the American Society of Infectious Diseases and Trust for America's Health, as well as developers of American antibiotics, large and small, have called on Congress to act quickly to enact a set of economic incentives. to reinvigorate the stagnant pipeline of antibiotics.

A number of congressional advocates urge concerned citizens to call their representatives, their senators and their representatives for what they advocate for resolute action on this vital or deadly issue.